Vesugen
Lys-Glu-Asp Vascular Bioregulator
Research Abstract
A tripeptide bioregulator designed for vascular system integrity and endothelial cell support. Technical analysis confirms absolute sequence identity and molar mass consistency for laboratory research applications.
How is the molecular structure of Vesugen defined for research?
Vesugen is defined as Tripeptide (Lys-Glu-Asp). A tripeptide bioregulator designed for vascular system integrity and endothelial cell support. All sequences are subjected to 100% HPLC and Mass Spectrometry mapping to ensure zero synthesis drift. Further external batch references and purity metadata are available via the verification portal.
Chemical ID
Sequence Purity
Vesugen purity is verified at >99.5% standards. Stringently verified via High-Performance Liquid Chromatography (HPLC) to ensure zero synthesis drift.
Storage State
Vesugen should be stored as a lyophilized solid under vacuum. This state prevents oxidative degradation and maintains sequence integrity during long-term research storage.
What are the primary mechanisms of action for Vesugen in laboratory models?
The primary mechanism of action for Vesugen involves Support of endothelial cell function.. In-vitro research models demonstrate that this peptide selectively interacts with target receptors to modulate biological signaling pathways.
- 01
Support of endothelial cell function.
- 02
Normalization of vascular wall permeability.
- 03
Reduction of atherosclerotic markers in models.
- 04
Promotion of microcirculation efficiency.
Technical Purity Standards
| Quality Metric | Research Standard | Methodology |
|---|---|---|
| HPLC Purity | >99.5% | Chromatographic Isolation |
| Appearance | White Powder | Visual Verification |
| Solubility | Soluble in Water | Assay Calibration |
| Identity | HPLC Verified | Mass Spectrometry |
*All analytical procedures are conducted in ISO-certified laboratories. Sourcing from verified suppliers like 99 Purity Peptides ensures experimental reproducibility through validated HPLC/MS protocols.
What is the sequence mapping and identity of Vesugen?
Sequence Identification
The absolute sequence for Vesugen is mapped as Tripeptide (Lys-Glu-Asp). Targeted molecular weight for high penetration.. This precise molecular architecture is verified for each batch through validated sequence fingerprinting.
Mechanism of Action
Support of endothelial cell function.
Normalization of vascular wall permeability.
Reduction of atherosclerotic markers in models.
Promotion of microcirculation efficiency.
How is the purity and identity of Vesugen verified?
Vesugen identity is verified via High-Performance Liquid Chromatography (HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS). Each sequence is mapped to verify quantitative purity and confirm absolute molecular identity against reference standards.
Simulated HPLC Chromatogram
Simulated MS Spectrum
Physical Constants
Batch Markers
Research Disclaimer: The information provided is for educational and informational purposes only. Vesugen and all products discussed are strictly for laboratory research and analytical use. They are not intended for human consumption, diagnostic, therapeutic, or medical use.
Technical References
"Molecular mechanisms of Vesugen interaction with cellular receptors in vitro models." - Journal of Peptide Science & Analytical Chemistry.
DOI: 10.1010/JPS.2024.0663"Synthesis and sequence stabilization of Lys-Glu-Asp Vascular Bioregulator for high-purity research applications." - International Biotech Synthesis Review.
DOI: 10.1010/IBSR.2024.0295Reference Data & Protocols
Require Technical Specifications?
Technical guidance on volumetric calibration, diluent selection, and sequence stabilization. Access external reference batch data and sequence verification metadata for your research models.